Caris Life Sciences (CAI) Research & Development (2024 - 2026)

Caris Life Sciences has reported Research & Development for 3 years, with the latest figure at $53.8 million in Q2 2026.

• On a quarterly basis, Research & Development rose 27.22% year-over-year to $53.8 million in Q2 2026; TTM through Jun 2026 was $184.2 million, a 17.81% increase from a year earlier, with the FY2025 full-year figure at $167.5 million, up 9.77% from the prior year.
• Research & Development was $53.8 million for Q2 2026 at Caris Life Sciences, up from $45.0 million in the prior quarter.
• The five-year high for Research & Development was $53.8 million in Q2 2026, with the low at $36.8 million in Q3 2024.
• Average Research & Development over 3 years is $42.1 million, with a median of $41.3 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Research & Development rose 9.17% in 2025, then advanced 27.22% in 2026.
• Over 3 years, Research & Development stood at $37.5 million in 2024, then rose by 17.66% to $44.2 million in 2025, then rose by 21.77% to $53.8 million in 2026.
• The last three Research & Development figures came in at $53.8 million (Q2 2026), $45.0 million (Q1 2026), and $44.2 million (Q4 2025), per Business Quant data.